DMK PHARMACEUTICALS Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary: DMK PHARMACEUTICALS Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q3 2023.
DMK PHARMACEUTICALS Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$1.39M, a 68.4% increase year-over-year.
DMK PHARMACEUTICALS Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$22.2M, a 30.4% increase year-over-year.
DMK PHARMACEUTICALS Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$26.5M, a 42.2% increase from 2021.
DMK PHARMACEUTICALS Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$45.8M, a 7.21% increase from 2020.
DMK PHARMACEUTICALS Corp annual Net Income (Loss) Attributable to Parent for 2020 was -$49.4M, a 79.5% decline from 2019.

Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)

Net Income (Loss) Attributable to Parent, Quarterly (USD)

Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	-$22.2M	-$1.39M	+$3.01M	+68.4%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	-$25.2M	-$8.57M	-$177K	-2.11%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-21
Q1 2023	-$25.1M	-$8.94M	+$1.41M	+13.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	-$26.5M	-$3.33M	+$5.45M	+62.1%	Oct 1, 2022	Dec 31, 2022	10-K	2023-03-16
Q3 2022	-$31.9M	-$4.4M	+$7.96M	+64.4%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	-$39.9M	-$8.4M	+$917K	+9.84%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-21
Q1 2022	-$40.8M	-$10.4M	+$5.02M	+32.7%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$45.8M	-$8.77M	+$9.08M	+50.9%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-16
Q3 2021	-$54.9M	-$12.4M	-$1M	-8.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$53.9M	-$9.31M	+$3.61M	+27.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021	-$57.5M	-$15.4M	-$8.13M	-112%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	-$49.4M	-$17.9M	-$14M	-359%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-31
Q3 2020	-$35.4M	-$11.4M	-$4.36M	-62.3%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-22
Q2 2020	-$31.1M	-$12.9M	-$5.19M	-67.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-11-22
Q1 2020	-$25.9M	-$7.25M	+$1.64M	+18.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-11-22
Q4 2019	-$27.5M	-$3.89M	+$8.92M	+69.6%	Oct 1, 2019	Dec 31, 2019	10-K	2021-04-15
Q3 2019	-$36.4M	-$7M	+$1.88M	+21.1%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	-$38.3M	-$7.74M	+$1.97M	+20.3%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-17
Q1 2019	-$40.3M	-$8.89M	-$1.27M	-16.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-18
Q4 2018	-$39M	-$12.8M	-$4.79M	-59.6%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-30
Q3 2018	-$34.2M	-$8.88M	-$2.11M	-31.1%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	-$32.1M	-$9.7M	-$4.73M	-95.2%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	-$27.4M	-$7.62M	-$1.85M	-32%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-08-08
Q4 2017	-$25.5M	-$8.03M	-$7.36M	-1098%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-15
Q3 2017	-$18.2M	-$6.77M	-$125K	-1.88%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-09
Q2 2017	-$18.1M	-$4.97M	+$743K	+13%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	-$18.8M	-$5.77M	+$636K	+9.92%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-10
Q4 2016	-$19.4M	-$670K	+$2.97M	+81.6%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-16
Q3 2016	-$22.4M	-$6.64M	-$3.5M	-111%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-14
Q2 2016	-$18.9M	-$5.71M	-$2.07M	-56.8%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-14
Q1 2016	-$16.8M	-$6.41M	-$3.27M	-104%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-12
Q4 2015	-$13.6M	-$3.64M	+$574K	+13.6%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-30
Q3 2015	-$14.1M	-$3.15M	-$1.02M	-48.2%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-14
Q2 2015	-$13.1M	-$3.64M	-$764K	-26.5%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-15
Q1 2015	-$12.4M	-$3.14M	-$1.59M	-102%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-13
Q4 2014	-$10.8M	-$4.21M	+$1.32M	+23.8%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-23
Q3 2014	-$12.1M	-$2.12M	-$2.09M	-6540%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-09
Q2 2014	-$9.99M	-$2.88M	-$1.84M	-176%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-07
Q1 2014	-$8.16M	-$1.55M	+$84.7K	+5.18%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-14
Q4 2013	-$8.24M	-$5.53M	-$3.56M	-180%	Oct 1, 2013	Dec 31, 2013	10-Q	2014-02-14
Q3 2013	-$4.69M	-$32K	+$825K	+96.3%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-14
Q2 2013	-$5.51M	-$1.04M	+$1.68M	+61.8%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-13
Q1 2013	-$7.19M	-$1.64M	-$431K	-35.7%	Jan 1, 2013	Mar 31, 2013	10-K	2014-06-23
Q4 2012	-$6.76M	-$1.97M	-$983K	-99.1%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-14
Q3 2012	-$5.78M	-$857K	+$620K	+42%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-13
Q2 2012	-$6.4M	-$2.73M	-$1.49M	-120%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-19
Q1 2012	-$4.92M	-$1.21M			Jan 1, 2012	Mar 31, 2012	10-K	2013-07-03
Q4 2011		-$991K	+$2.1M	+68%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-19
Q3 2011		-$1.48M			Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-13
Q2 2011		-$1.24M			Apr 1, 2011	Jun 30, 2011	10-Q/A	2012-08-17
Q4 2010		-$3.09M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.